Literature DB >> 20969853

Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

Dove J Keith1, Amy J Eshleman, Aaron Janowsky.   

Abstract

Phospholipase A(2) releases the fatty acid arachidonic acid from membrane phospholipids. We used the purported phospholipase A(2) stimulator, melittin, to examine the effects of endogenous arachidonic acid signaling on dopamine transporter function and trafficking. In HEK-293 cells stably transfected with the dopamine transporter, melittin reduced uptake of [((3))H]dopamine. Additionally, measurements of fatty acid content demonstrated a melittin-induced release of membrane-incorporated arachidonic acid, but inhibitors of phospholipase C, phospholipase D, and phospholipase A(2) did not prevent the release. Subsequent experiments measuring [(125)I]RTI-55 binding to the dopamine transporter demonstrated a direct interaction of melittin, or a melittin-activated endogenous compound, with the transporter to inhibit antagonist binding. This effect was not specific to the dopamine transporter, as [(3)H]spiperone binding to the recombinant dopamine D(2) receptor was also inhibited by melittin treatment. Finally, melittin stimulated an increase in internalization of the dopamine transporter, and this effect was blocked by pretreatment with cocaine. Thus, melittin acts through multiple mechanisms to regulate cellular activity, including release of membrane-incorporated fatty acids and interaction with the dopamine transporter. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969853      PMCID: PMC3125126          DOI: 10.1016/j.ejphar.2010.10.023

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  56 in total

Review 1.  Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake.

Authors:  R M Wightman; J B Zimmerman
Journal:  Brain Res Brain Res Rev       Date:  1990 May-Aug

Review 2.  Diversity of group types, regulation, and function of phospholipase A2.

Authors:  E A Dennis
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

Review 3.  Quantitative approaches to in vivo brain microdialysis.

Authors:  L H Parsons; J B Justice
Journal:  Crit Rev Neurobiol       Date:  1994

4.  Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4.

Authors:  W A Fairman; M S Sonders; G H Murdoch; S G Amara
Journal:  Nat Neurosci       Date:  1998-06       Impact factor: 24.884

5.  Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway.

Authors:  L Zhang; M E Reith
Journal:  Eur J Pharmacol       Date:  1996-11-21       Impact factor: 4.432

6.  Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.

Authors:  A Volterra; D Trotti; G Racagni
Journal:  Mol Pharmacol       Date:  1994-11       Impact factor: 4.436

Review 7.  Phospholipase A2 enzymes: regulation and inhibition.

Authors:  K B Glaser; D Mobilio; J Y Chang; N Senko
Journal:  Trends Pharmacol Sci       Date:  1993-03       Impact factor: 14.819

8.  Effects of melittin on lipid-protein interactions in sarcoplasmic reticulum membranes.

Authors:  J E Mahaney; J Kleinschmidt; D Marsh; D D Thomas
Journal:  Biophys J       Date:  1992-12       Impact factor: 4.033

Review 9.  The membrane hypothesis of schizophrenia.

Authors:  D F Horrobin; A I Glen; K Vaddadi
Journal:  Schizophr Res       Date:  1994-10       Impact factor: 4.939

10.  Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

Authors:  I P Street; H K Lin; F Laliberté; F Ghomashchi; Z Wang; H Perrier; N M Tremblay; Z Huang; P K Weech; M H Gelb
Journal:  Biochemistry       Date:  1993-06-15       Impact factor: 3.162

View more
  6 in total

1.  Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells.

Authors:  Dove J Keith; Katherine Wolfrum; Amy J Eshleman; Aaron Janowsky
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

2.  Melittin modulates keratinocyte function through P2 receptor-dependent ADAM activation.

Authors:  Anselm Sommer; Anja Fries; Isabell Cornelsen; Nancy Speck; Friedrich Koch-Nolte; Gerald Gimpl; Jörg Andrä; Sucharit Bhakdi; Karina Reiss
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

3.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

4.  Production of antibacterial peptide from bee venom via a new strategy for heterologous expression.

Authors:  Chunsheng Hou; Liqiong Guo; Junfang Lin; Linfeng You; Wuhua Wu
Journal:  Mol Biol Rep       Date:  2014-09-05       Impact factor: 2.316

5.  Melittin restores proteasome function in an animal model of ALS.

Authors:  Eun Jin Yang; Seon Hwy Kim; Sun Choel Yang; Sang Min Lee; Sun-Mi Choi
Journal:  J Neuroinflammation       Date:  2011-06-20       Impact factor: 8.322

Review 6.  Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests.

Authors:  Rim Wehbe; Jacinthe Frangieh; Mohamad Rima; Dany El Obeid; Jean-Marc Sabatier; Ziad Fajloun
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.